Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Circulating activated platelets in myeloproliferative disorders.

A Wehmeier1, D Tschöpe, J Esser

  • 1Department of Haematology, Oncology and Clinical Immunology, Heinrich-Heine University, Düsseldorf, FRG.

Thrombosis Research
|February 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LiDAR demonstration using an InP-based optical phased array with a 3D-printed beam-shaping element.

Optics express·2026
Same author

Targeted next-generation sequencing of circulating free DNA enables non-invasive tumor detection in myxoid liposarcomas.

Molecular cancer·2022
Same author

Varying development of femoral and tibial subchondral bone tissue and their interaction with articular cartilage during progressing osteoarthritis.

Archives of orthopaedic and trauma surgery·2020
Same author

[Heart failure and diabetes-underestimated, poorly understood and too rarely diagnosed].

Herz·2019
Same author

Cardiovascular outcome in type 2 diabetes and atrial fibrillation.

Herz·2018
Same author

[Evaluation of the medical treatment situation of the visually impaired : Significant differences between young and old].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2018
Same journal

Apoptotic versus procoagulant platelets: similar "necrotic" phenotype and procoagulant activity in vitro, but distinct adhesive protein composition.

Thrombosis research·2026
Same journal

Heatstroke-induced coagulopathy: A scoping review of therapeutic strategies and outcome reporting.

Thrombosis research·2026
Same journal

Mapping thrombus habitat: Non-contrast MRI radiomics and pixel-tile histomics approach to track venous thrombosis evolution in mice.

Thrombosis research·2026
Same journal

A study protocol for a randomised controlled trial evaluating the safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography only for suspected acute pulmonary embolism in patients with cancer: the Hydra Study.

Thrombosis research·2026
Same journal

Associating the phenotypic expression of platelets with disease type through image-based single-cell profiling.

Thrombosis research·2026
Same journal

The mechanisms of contractile dysfunction following chronic limited platelet activation in (pro)thrombotic conditions.

Thrombosis research·2026
See all related articles

Activated platelets circulate in some myeloproliferative disorder patients, indicated by increased platelet activation markers. Further research is needed to link these findings to bleeding and thrombotic complications.

Area of Science:

  • Hematology
  • Oncology
  • Platelet Biology

Background:

  • Myeloproliferative disorders (MPDs) are associated with platelet abnormalities, including altered granule secretion.
  • Assessing platelet activation is crucial for understanding MPD pathophysiology and associated complications.

Purpose of the Study:

  • To investigate the presence of circulating activated platelets in patients with chronic myeloproliferative disorders.
  • To correlate platelet activation markers with clinical complications such as bleeding and thrombosis.

Main Methods:

  • Evaluated binding of activation-dependent monoclonal antibodies (P-12, CD63, CD62) on platelets from 12 MPD patients.
  • Assessed platelet aggregation in response to various agonists and ristocetin agglutination.
  • Correlated antibody binding with clinical history of thrombohemorrhagic events.

Related Experiment Videos

Main Results:

  • Increased platelet activation markers were observed in 3 out of 12 patients, with a trend in 2 others.
  • Binding of anti-thrombospondin (P-12) correlated with GMP-140 (CD62) expression (r=0.76, p=0.004).
  • Circulating activated platelets were detected in 3 of 5 patients with a history of bleeding or thrombosis.

Conclusions:

  • Some patients with myeloproliferative disorders exhibit increased levels of circulating activated platelets.
  • The direct link between platelet activation markers and clinical complications in MPDs requires further investigation.